Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...

AtriCure announced the successful first-in-human AFib treatments using its novel dual-energy surgical cardiac ablation platform.

Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...

London, United Kingdom – 1 September 2024: Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the ...

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone. In a new study published in Heart Rhythm, researchers ...

( Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced ...

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic ...

Atrial fibrillation (AFib) is the most prevalent form of cardiac arrhythmia, affecting a significant portion of the global population. Often marked by irregular and rapid heartbeats, AFib presents a ...

DUBLIN--(BUSINESS WIRE)--The "Cardiac Ablation - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The Cardiac Ablation market worldwide is projected ...

Study incorporated data from over 25,000 patients across 30 sites and compared proactive esophageal cooling to luminal temperature monitoring during RF ablation of the left atrium. CHICAGO--(BUSINESS ...

MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices advisory panel voted against the Medtronic Phased RF Ablation System, the ...